CD68 and seminoma: Sam et al. performed immunohistochemistry in 51 seminomas and 26 non-seminomatous germ cell tumors, and found that germ cell tumors primarily expressed PD-L1 (a known checkpoint in tumor immunity) on tumor-associated CD68+ macrophages [31].